Skip to main content
. 2023 Oct 16;22(1):2–12. doi: 10.9758/cpn.23.1120

Table 1.

Characteristics of each study included

ID Study/year Study design Sample size Sample mean age (years ± SD) Sex (F/M)
A1 Carhart-Harris et al., 2021 [34] Randomised n = 30 treatment group 43.3 ± 11.7 11/19
A2 Davis et al., 2021 [35] Randomised n = 13 treatment group 43.6 ± 13.0 9/4
A3 Carhart-Harris et al., 2016 [33] Open-label trial n = 12 42.7 ± 10.2 6/6
A4 Lyons et al., 2018 [37] Open-label trial n = 15 treatment group 45.4 ± 2.9 4/11
A5 Carhart-Harris et al., 2017 [23] Open-label trial n = 16 42.8 ± 10.1 4/12
A6.a Goodwin et al., 2022 [36] Randomised n = 79 (group A) 40.2 ± 12.2 44/79
A6.b n = 75 (group B) 40.6 ± 12.8 41/75
A6.c n = 79 (group C) 38.7 ± 11.7 36/79

SD, standard deviation; F, female; M, male.